NF-κB p65 Protein
Overview
NF-κB p65 (also known as RelA or p65/RelA) is a 65-kilodalton protein and the principal transcriptionally active subunit of the nuclear factor-kappa B (NF-κB) signaling complex. This protein belongs to the Rel family of transcription factors and functions as a key regulatory molecule in inflammatory responses, cell survival, and gene expression. The p65 subunit predominantly forms dimers with p50, another NF-κB family member, creating the classically active NF-κB complex. In healthy neurons, NF-κB signaling maintains relatively low basal activity; however, in neurodegenerative diseases, dysregulated NF-κB p65 activation contributes significantly to pathological neuroinflammation and neuronal death.
Function/Biology
NF-κB p65 functions primarily as a ligand-activated transcription factor that regulates genes involved in inflammation, immunity, and cell survival. The p65 protein contains several critical structural domains: a Rel homology domain (RHD) responsible for DNA binding and dimerization, a transactivation domain (TAD) that recruits coactivators, and regulatory regions subject to phosphorylation and acetylation. In the cytoplasm, p65 exists in an inactive state, sequestered by inhibitory κB proteins (IκBs), predominantly IκBα. Upon stimulation by tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), or lipopolysaccharide (LPS), IκB kinase (IKK) phosphorylates IκBα, leading to its ubiquitin-mediated degradation and liberation of p65.
...NF-κB p65 Protein
Overview
NF-κB p65 (also known as RelA or p65/RelA) is a 65-kilodalton protein and the principal transcriptionally active subunit of the nuclear factor-kappa B (NF-κB) signaling complex. This protein belongs to the Rel family of transcription factors and functions as a key regulatory molecule in inflammatory responses, cell survival, and gene expression. The p65 subunit predominantly forms dimers with p50, another NF-κB family member, creating the classically active NF-κB complex. In healthy neurons, NF-κB signaling maintains relatively low basal activity; however, in neurodegenerative diseases, dysregulated NF-κB p65 activation contributes significantly to pathological neuroinflammation and neuronal death.
Function/Biology
NF-κB p65 functions primarily as a ligand-activated transcription factor that regulates genes involved in inflammation, immunity, and cell survival. The p65 protein contains several critical structural domains: a Rel homology domain (RHD) responsible for DNA binding and dimerization, a transactivation domain (TAD) that recruits coactivators, and regulatory regions subject to phosphorylation and acetylation. In the cytoplasm, p65 exists in an inactive state, sequestered by inhibitory κB proteins (IκBs), predominantly IκBα. Upon stimulation by tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), or lipopolysaccharide (LPS), IκB kinase (IKK) phosphorylates IκBα, leading to its ubiquitin-mediated degradation and liberation of p65.
Once released, p65 translocates to the nucleus where it binds to DNA sequences called κB sites (consensus sequence GGGACTTTCC) in the promoter and enhancer regions of target genes. The p65 subunit provides most of the transactivation capacity of the NF-κB dimer through its two transactivation domains (TAD1 and TAD2), recruiting histone acetyltransferases and other coactivators necessary for robust gene transcription. p65 activity is regulated through post-translational modifications including phosphorylation at serine 536 (by IKKβ and other kinases), serine 276 (by protein kinase A and ribosomal S6 kinase), and acetylation at multiple lysine residues, which enhance its transcriptional capacity.
Role in Neurodegeneration
In neurodegenerative diseases, inappropriate NF-κB p65 activation perpetuates chronic neuroinflammation, a hallmark pathological process. In Alzheimer's disease, amyloid-beta peptide and tau tangles activate microglial NF-κB p65 signaling, promoting the production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. This neuroinflammatory cascade exacerbates neuronal death and accelerates cognitive decline. In Parkinson's disease, alpha-synuclein aggregates similarly drive p65 activation in glial cells, perpetuating sustained release of neurotoxic factors. In amyotrophic lateral sclerosis (ALS), mutant SOD1 and C9orf72 repeat expansions activate NF-κB p65 signaling in motor neurons and astrocytes, promoting inflammatory cytokine production and motor neuron degeneration. Additionally, dysregulated p65 activity impairs the balance between pro-survival and pro-death signaling, shifting neurons toward apoptotic pathways.
Molecular Mechanisms
NF-κB p65 controls transcription of genes encoding pro-inflammatory mediators (TNF-α, IL-6, iNOS, COX-2), anti-apoptotic proteins (Bcl-2, Bcl-xL), and chemokines (CCL2, CXCL10). In neurodegeneration, excessive p65 transactivation increases expression of factors that perpetuate inflammation and promote neuronal death. Pathogenic proteins (amyloid-beta, alpha-synuclein, mutant huntingtin) activate p65 through pattern recognition receptor signaling and oxidative stress pathways. Simultaneously, p65 phosphorylation at serine 536 by IKKβ represents a particularly aggressive activation state associated with severe neuroinflammation. Crosstalk between NF-κB p65 and other pathways—including MAPK signaling and JAK-STAT pathways—amplifies inflammatory responses.
Clinical/Research Significance
Therapeutic targeting of NF-κB p65 represents a strategy for reducing pathological neuroinflammation in neurodegeneration. IκB kinase inhibitors, direct p65 antagonists, and agents that promote IκBα restoration show promise in preclinical models. Understanding p65 regulation provides insights into the transition from acute, protective inflammation to chronic, pathological neuroinflammation—a critical distinction for developing disease-modifying therapeutics.
Pathway Diagram
The following diagram shows the key molecular relationships involving NF-κB p65 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)